251 related articles for article (PubMed ID: 26463566)
21. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.
de Jong DS; van Zoelen EJ; Bauerschmidt S; Olijve W; Steegenga WT
J Bone Miner Res; 2002 Dec; 17(12):2119-29. PubMed ID: 12469906
[TBL] [Abstract][Full Text] [Related]
23. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells.
Knutsen R; Honda Y; Strong DD; Sampath TK; Baylink DJ; Mohan S
Endocrinology; 1995 Mar; 136(3):857-65. PubMed ID: 7532581
[TBL] [Abstract][Full Text] [Related]
24. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
Fromigué O; Haÿ E; Modrowski D; Bouvet S; Jacquel A; Auberger P; Marie PJ
Cell Death Differ; 2006 Nov; 13(11):1845-56. PubMed ID: 16470222
[TBL] [Abstract][Full Text] [Related]
25. Construction of antisense transforming growth factor beta 1 gene and its effect on the proliferation by expression in osteosarcoma cells.
Liu Y; Zheng Q; Du J; Yang S; Shao Z; Xiao B
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):163-5. PubMed ID: 12973938
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
27. MET overexpression turns human primary osteoblasts into osteosarcomas.
Patanè S; Avnet S; Coltella N; Costa B; Sponza S; Olivero M; Vigna E; Naldini L; Baldini N; Ferracini R; Corso S; Giordano S; Comoglio PM; Di Renzo MF
Cancer Res; 2006 May; 66(9):4750-7. PubMed ID: 16651428
[TBL] [Abstract][Full Text] [Related]
28. PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines.
Bilbe G; Roberts E; Birch M; Evans DB
Bone; 1996 Nov; 19(5):437-45. PubMed ID: 8922641
[TBL] [Abstract][Full Text] [Related]
29. IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma.
Kuijjer ML; Peterse EF; van den Akker BE; Briaire-de Bruijn IH; Serra M; Meza-Zepeda LA; Myklebost O; Hassan AB; Hogendoorn PC; Cleton-Jansen AM
BMC Cancer; 2013 May; 13():245. PubMed ID: 23688189
[TBL] [Abstract][Full Text] [Related]
30. Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells.
Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
Int J Cancer; 1994 Aug; 58(3):440-5. PubMed ID: 8050825
[TBL] [Abstract][Full Text] [Related]
31. IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma.
MacEwen EG; Pastor J; Kutzke J; Tsan R; Kurzman ID; Thamm DH; Wilson M; Radinsky R
J Cell Biochem; 2004 May; 92(1):77-91. PubMed ID: 15095405
[TBL] [Abstract][Full Text] [Related]
32. Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.
Dalla-Torre CA; Yoshimoto M; Lee CH; Joshua AM; de Toledo SR; Petrilli AS; Andrade JA; Chilton-MacNeill S; Zielenska M; Squire JA
BMC Cancer; 2006 Oct; 6():237. PubMed ID: 17022822
[TBL] [Abstract][Full Text] [Related]
33. Frequent reduction or loss of DCC gene expression in human osteosarcoma.
Horstmann MA; Pösl M; Scholz RB; Anderegg B; Simon P; Baumgaertl K; Delling G; Kabisch H
Br J Cancer; 1997; 75(9):1309-17. PubMed ID: 9155051
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.
Le Nail LR; Brennan M; Rosset P; Deschaseaux F; Piloquet P; Pichon O; Le Caignec C; Crenn V; Layrolle P; Hérault O; De Pinieux G; Trichet V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29494553
[TBL] [Abstract][Full Text] [Related]
35. Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines.
Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
Eur J Cancer; 1994; 30A(5):678-82. PubMed ID: 8080687
[TBL] [Abstract][Full Text] [Related]
36. Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma.
Arihiro K; Inai K
Pathol Int; 2001 Feb; 51(2):100-6. PubMed ID: 11169148
[TBL] [Abstract][Full Text] [Related]
37. Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma.
Burrow S; Andrulis IL; Pollak M; Bell RS
J Surg Oncol; 1998 Sep; 69(1):21-7. PubMed ID: 9762887
[TBL] [Abstract][Full Text] [Related]
38. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11851-6. PubMed ID: 18697945
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of the sis oncogene in a canine osteosarcoma cell line.
Levine RA
Vet Pathol; 2002 May; 39(3):411-2. PubMed ID: 12014510
[TBL] [Abstract][Full Text] [Related]
40. Relation between histological intensity of transforming growth factor-beta isoforms in human osteosarcoma and the rate of lung metastasis.
Yang RS; Wu CT; Lin KH; Hong RL; Liu TK; Lin KS
Tohoku J Exp Med; 1998 Feb; 184(2):133-42. PubMed ID: 9605020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
